Optas LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 5.1% during the 4th quarter, HoldingsChannel.com reports. The fund owned 3,824 shares of the healthcare conglomerate’s stock after selling 207 shares during the period. Optas LLC’s holdings in UnitedHealth Group were worth $1,934,000 as of its most recent SEC filing.
Several other institutional investors have also recently made changes to their positions in UNH. Quarry LP grew its position in shares of UnitedHealth Group by 132.1% in the 2nd quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after acquiring an additional 37 shares during the period. AMF Tjanstepension AB increased its position in UnitedHealth Group by 88.0% during the third quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate’s stock worth $151,374,000 after buying an additional 121,180 shares during the last quarter. Czech National Bank boosted its stake in shares of UnitedHealth Group by 7.3% during the 3rd quarter. Czech National Bank now owns 188,110 shares of the healthcare conglomerate’s stock worth $109,984,000 after acquiring an additional 12,721 shares during the period. GAMMA Investing LLC raised its stake in UnitedHealth Group by 41.0% in the 3rd quarter. GAMMA Investing LLC now owns 14,393 shares of the healthcare conglomerate’s stock valued at $8,415,000 after acquiring an additional 4,187 shares during the period. Finally, WealthBridge Capital Management LLC increased its holdings in shares of UnitedHealth Group by 42.2% in the third quarter. WealthBridge Capital Management LLC now owns 1,942 shares of the healthcare conglomerate’s stock valued at $1,135,000 after purchasing an additional 576 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.
Analyst Upgrades and Downgrades
A number of brokerages recently commented on UNH. Wells Fargo & Company decreased their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Barclays reduced their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. UBS Group dropped their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Truist Financial lowered their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Finally, Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $629.32.
Insider Transactions at UnitedHealth Group
In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.33% of the company’s stock.
UnitedHealth Group Trading Up 1.1 %
Shares of NYSE UNH opened at $548.65 on Tuesday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The stock has a market cap of $504.91 billion, a P/E ratio of 35.40, a price-to-earnings-growth ratio of 1.48 and a beta of 0.61. The firm has a 50 day moving average price of $536.17 and a two-hundred day moving average price of $565.20.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $5.83 earnings per share. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 29.63 EPS for the current year.
UnitedHealth Group Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.53%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.19%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- How to Invest in Small Cap Stocks
- What Are Some of the Best Large-Cap Stocks to Buy?
- These Are the Dividend Stocks Insiders Bought in January
- Following Congress Stock Trades
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.